Cartesian Therapeutics Inc
RNAC
ISIN US8162123025 / Valor 134256445
Cartesian Therapeutics Inc
UMushroom community rating:
About company
Cartesian Therapeutics Inc. is a biotechnology company specializing in the development of RNA cell therapies for autoimmune, oncologic, and respiratory diseases. The company leverages its proprietary RNA Armory platform to engineer cell therapies that can be precisely controlled and directed to target specific disease mechanisms. Cartesian's lead product candidates include Descartes-08, an RNA-engineered cell therapy for myasthenia gravis, and Descartes-11, aimed at treating multiple myeloma. The company is focused on advancing these therapies through clinical trials to address unmet medical needs in these complex conditions.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
2691 M
Market cap (USD)
54,713
Daily traded volume (Shares)
17.37 / 16.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
